Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Icon Plc (ICLR)

Icon Plc (ICLR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,874,909
  • Shares Outstanding, K 53,971
  • Annual Sales, $ 2,596 M
  • Annual Income, $ 322,660 K
  • 60-Month Beta 0.69
  • Price/Sales 3.02
  • Price/Cash Flow 19.10
  • Price/Book 5.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.83
  • Number of Estimates 7
  • High Estimate 1.84
  • Low Estimate 1.81
  • Prior Year 1.62
  • Growth Rate Est. (year over year) +12.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
138.50 +5.55%
on 10/16/19
152.06 -3.87%
on 10/29/19
+4.00 (+2.81%)
since 10/11/19
3-Month
138.50 +5.55%
on 10/16/19
158.86 -7.98%
on 08/19/19
-10.03 (-6.42%)
since 08/09/19
52-Week
118.10 +23.78%
on 01/03/19
165.13 -11.48%
on 07/26/19
+7.72 (+5.58%)
since 11/09/18

Most Recent Stories

More News
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ICLR : 146.18 (+0.19%)
ICON Reports Third Quarter 2019 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third...

ICLR : 146.18 (+0.19%)
ICON's Acquisition of Symphony Clinical Research

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today announced that it has acquired...

ICLR : 146.18 (+0.19%)
Icon PLC: 3Q Earnings Snapshot

DUBLIN (AP) _ Icon PLC (ICLR) on Wednesday reported third-quarter net income of $94.8 million.

ICLR : 146.18 (+0.19%)
ICON plc to Present at Baird's 2019 Global Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve...

ICLR : 146.18 (+0.19%)
ERFSF vs. ICLR: Which Stock Should Value Investors Buy Now?

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

ERFSF : 490.0000 (-2.39%)
ICLR : 146.18 (+0.19%)
ERFSF vs. ICLR: Which Stock Is the Better Value Option?

ERFSF vs. ICLR: Which Stock Is the Better Value Option?

ERFSF : 490.0000 (-2.39%)
ICLR : 146.18 (+0.19%)
Icon PLC (ICLR) Tops Q2 Earnings and Revenue Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.60% and 0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

ICLR : 146.18 (+0.19%)
Icon PLC: 2Q Earnings Snapshot

DUBLIN (AP) _ Icon PLC (ICLR) on Wednesday reported second-quarter earnings of $91.9 million.

ICLR : 146.18 (+0.19%)
ICON Reports Second Quarter 2019 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second...

ICLR : 146.18 (+0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade ICLR with:

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

2nd Resistance Point 147.23
1st Resistance Point 146.71
Last Price 146.18
1st Support Level 145.38
2nd Support Level 144.58

See More

52-Week High 165.13
Fibonacci 61.8% 147.17
Last Price 146.18
Fibonacci 50% 141.62
Fibonacci 38.2% 136.07
52-Week Low 118.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar